Literature DB >> 8519386

Steroid resistant asthma: what is the clinical definition?

A J Woolcock1.   

Abstract

Asthma is usually a steroid responsive disease. A few patients respond poorly to these drugs, and others need such high doses to control the disease that side-effects become a serious problem. The term steroid resistant asthma is used for both groups. In some patients, factors may be operating to make the asthma worse and, thus, to increase the requirement for steroids. In order to make a clinical diagnosis of steroid resistant asthma, it is therefore necessary to investigate the factors that could be operating to prevent a "normal" response to steroids. These factors include wrong diagnosis, insufficient steroid reaching the airway mucosa, continuing exposure to sensitizing agents, unrecognized aggravating agents, excessive use of beta-agonist aerosols, and failure to undertake regular management according to a strict management plan. Using a strict clinical definition of steroid resistant asthma leads to better investigation and treatment of individual patients, allows steroids to be stopped when they are not indicated, allows other anti-inflammatory drugs to be used with confidence, and provides a well-defined group of patients for further research relating to the mechanisms of action of steroids.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8519386

Source DB:  PubMed          Journal:  Eur Respir J        ISSN: 0903-1936            Impact factor:   16.671


  12 in total

1.  Profiling of genes expressed in peripheral blood mononuclear cells predicts glucocorticoid sensitivity in asthma patients.

Authors:  Hakon Hakonarson; Unnur S Bjornsdottir; Eva Halapi; Jonathan Bradfield; Florian Zink; Magali Mouy; Hildur Helgadottir; Asta S Gudmundsdottir; Hjalti Andrason; Asdis E Adalsteinsdottir; Kristleifur Kristjansson; Illugi Birkisson; Thor Arnason; Margret Andresdottir; David Gislason; Thorarinn Gislason; Jeffrey R Gulcher; Kari Stefansson
Journal:  Proc Natl Acad Sci U S A       Date:  2005-10-03       Impact factor: 11.205

Review 2.  Could NSAIDs have a role as antiasthmatic agents?

Authors:  S Bianco; M G Pieroni; R M Refini; M Robuschi; A Vaghi; P Sestini
Journal:  Drugs       Date:  1994-07       Impact factor: 9.546

Review 3.  Canadian Asthma Consensus Report, 1999. Canadian Asthma Consensus Group.

Authors:  L P Boulet; A Becker; D Bérubé; R Beveridge; P Ernst
Journal:  CMAJ       Date:  1999-11-30       Impact factor: 8.262

4.  Pseudo-steroid resistant asthma.

Authors:  P S Thomas; D M Geddes; P J Barnes
Journal:  Thorax       Date:  1999-04       Impact factor: 9.139

5.  Single-cell transcriptomic analysis reveals the immune landscape of lung in steroid-resistant asthma exacerbation.

Authors:  Lingli Wang; Keilah G Netto; Lujia Zhou; Xiaojie Liu; Ming Wang; Guojun Zhang; Paul S Foster; Fuguang Li; Ming Yang
Journal:  Proc Natl Acad Sci U S A       Date:  2021-01-12       Impact factor: 11.205

6.  The Difficult-to-Control Asthmatic: A Systematic Approach.

Authors:  Annie V Le; Ronald A Simon
Journal:  Allergy Asthma Clin Immunol       Date:  2006-09-15       Impact factor: 3.406

Review 7.  Severe asthma.

Authors:  Nicholas J Kenyon; Nizar N Jarjour
Journal:  Clin Rev Allergy Immunol       Date:  2003-10       Impact factor: 8.667

Review 8.  Difficult-to-control asthma management through the use of a specific protocol.

Authors:  Pedro Giavina-Bianchi; Marcelo Vivolo Aun; Carla Bisaccioni; Rosana Agondi; Jorge Kalil
Journal:  Clinics (Sao Paulo)       Date:  2010       Impact factor: 2.365

Review 9.  Clinical review: severe asthma.

Authors:  Spyros Papiris; Anastasia Kotanidou; Katerina Malagari; Charis Roussos
Journal:  Crit Care       Date:  2001-11-22       Impact factor: 9.097

10.  Clinical and molecular aspects of glucocorticoid resistant asthma.

Authors:  Chris J Corrigan; Tuck-Kay Loke
Journal:  Ther Clin Risk Manag       Date:  2007-10       Impact factor: 2.423

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.